3 withdrawn. 3 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 3 |
| Phase 3 | 3 | Withdrawn 3 |
Follow Burn: new trials by email Literature Review of Burn trials Research Report on Burn
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate fenofibrate, placebo - Burn | Phase 2 / Phase 3 | Withdrawn | The University of Texas Medical Branch, Galveston | 2008-08-01 | 2012-12-11 | |
| New Treatment for Donor Sites Application of donor site dressing [scarlet red, Microbial Nanocellulose (NC), or hyaluronan and thrombin (HT)], Blood sample, Biopsy - Burn | Phase 2 / Phase 3 | Withdrawn | The University of Texas Medical Branch, Galveston | 2006-01-01 | 2012-12-11 | |
| Use of Amnion on Partial Thickness Burns Amnion, Polysporin/Bacitracin/Mycostatin - Burn | Phase 2 / Phase 3 | Withdrawn | The University of Texas Medical Branch, Galveston | 2005-06-01 | 2012-11-15 |
Burns (3) · Cicatrix (1) · Insulin Resistance (1) · Wounds and Injuries (1)
Wounds and Injuries (2) · Fibrosis (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Biopsy (1) · Blood Specimen Collection (1) · Fenofibrate (1) · Hyaluronic Acid (1) · Scarlet Red (1) · Thrombin (1) · bacitracin, polymyxin B drug combination (1) · cancer procoagulant (1)
The University of Texas Medical Branch, Galveston (3)
David N Herndon, MD (2) · David Herndon, MD (1)